Quick Takeaways
- Karpus Management, Inc. filed SCHEDULE 13G for Drugs Made In America Acquisition Corp. Common (DMAA).
- Disclosed ownership: 6.9%.
- Date of event: 31 Mar 2025.
Karpus Management, Inc. - 31 Mar 2025 SCHEDULE 13G Report for Drugs Made In America Acquisition Corp. Common (DMAA)
- Filing Manager
- Karpus Management, Inc.
- Reporting Manager
- KARPUS MANAGEMENT, INC.
- Symbol
- DMAA
- Shares outstanding
- 33,535,844 shares
- Disclosed Ownership
- 2,324,034 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G
- Filing time
- 14 May 2025, 16:04:02 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Karpus Management, Inc. disclosed 6.9% ownership in Drugs Made In America Acquisition Corp. Common (DMAA) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 16:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| KARPUS MANAGEMENT, INC. | 6.9% | 2,324,034 | 2,324,034 | 0 | /s/ Jodi L. Hedberg | Jodi L. Hedberg / Chief Compliance Officer |